🇯🇵·12h agoRegulatory
[SHINSA]English Translation of Review Report: SUSMED App for Insomnia Medcle (Partial Change Approval)
Publisher
P
PMDA Japan
Japan
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- PMDA Japan
- Region
- Japan
- Scope
- Regulatory
- Published
- June 30, 2026
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on pmda.go.jp
Leave the platform to read the original full article on the publisher site.
Source: PMDA Japan
Scope: Regulatory
Related coverage
More related coverage
openFDA Drug Labels/-522m ago
Drug label update: Evereden Kids Mineral Sunscreen SPF 30
Official structured record identifier: bba219a4-de83-76fd-e053-2995a90a2d69.
openFDA Drug Labels/-522m ago
Drug label update: GUNA-VIRUS
Official structured record identifier: 53e741c4-8897-71f3-e063-6394a90a751d.
MHRA UK/5h ago
Class 4 Medicines Defect Notification: Relonchem Limited, Gabapentin Relonchem 50mg/ml Oral Solution, EL(26)A/31
ABPI UK/6h ago